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Abstract
How easy is it to reproduce the results found in a typical computational biology paper? Either through experience or
intuition the reader will already know that the answer is with difficulty or not at all. In this paper we attempt to quantify this
difficulty by reproducing a previously published paper for different classes of users (ranging from users with little expertise
to domain experts) and suggest ways in which the situation might be improved. Quantification is achieved by estimating
the time required to reproduce each of the steps in the method described in the original paper and make them part of an
explicit workflow that reproduces the original results. Reproducing the method took several months of effort, and required
using new versions and new software that posed challenges to reconstructing and validating the results. The quantification
leads to ‘‘reproducibility maps’’ that reveal that novice researchers would only be able to reproduce a few of the steps in the
method, and that only expert researchers with advance knowledge of the domain would be able to reproduce the method
in its entirety. The workflow itself is published as an online resource together with supporting software and data. The paper
concludes with a brief discussion of the complexities of requiring reproducibility in terms of cost versus benefit, and a
desiderata with our observations and guidelines for improving reproducibility. This has implications not only in reproducing
the work of others from published papers, but reproducing work from one’s own laboratory.
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computational artifact, could be analyzed and re-run automatically. Consequently, workflows can make scientists more productive because they capture complex methods in an easy to use
accessible manner [2–3].
The goal of this article is, by applying a workflow to an existing
computational analysis [4], to describe and quantify the effort
involved in reproducing the published computational method and
to articulate guidelines for authors that would facilitate reproducibility and reuse. Quantification is achieved by assigning a
reproducibility score that exposes the cost of omitting important
information from the published paper that then caused problems
in creating the workflow. Beyond this no case is made for the value
of workflows which is well described elsewhere [3].

Introduction
Computation is now an integral part of the biological sciences
either applied as a technique or as a science in its own right bioinformatics. As a technique, software becomes an instrument to
analyze data and uncover new biological insights. By reading the
published article describing these insights, another researcher
hopes to understand what computations were carried out, replicate
the software apparatus originally used and reproduce the
experiment. This is rarely the case without significant effort, and
sometimes impossible without asking the original authors. In short,
reproducibility in computational biology is aspired to, but rarely
achieved. This is unfortunate since the quantitative nature of the
science makes reproducibility more obtainable than in cases where
experiments are qualitative and hard to describe explicitly.
An intriguing possibility where potential quantification exists is
to extend articles through the inclusion of scientific workflows that
represent computations carried out to obtain the published results,
thereby capturing data analysis methods explicitly [1]. This would
make scientific results more reproducible because articles would
have not only a textual description of the computational process
described in the article but also a workflow that, as a
PLOS ONE | www.plosone.org

Related Work
As stated, scientific articles describe computational methods
informally, as the computational aspects of the method may not be
the main focus of the article. We acknowledge that in computer
science the method may be described formally and any limitations,
it could be argued, reside with the editors and reviewers. However,
in the domain of computational biology, which is the focus here,
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which compares the binding site of the drug bound to a primary
protein receptor to potential binding sites found on every available
protein in a given proteome. Docking of the drug to the off-target
protein is used to further validate the predicted binding. The study
uses data from the RCSB Protein Data Bank (PDB [33]) and
Modbase [34]. The resultant ‘‘drugome’’ established multiple
receptors to which a given drug can bind and multiple drugs that
could bind to a given receptor. As such it is a putative map of
possible drug repositioning strategies in treating a given condition
caused by a pathogen. Although the article focuses on Mycobacterium tuberculosis (TB), according to the article’s abstract:
‘‘… the methodology may be applied to other pathogens of
interest with results improving as more of their structural
proteomes are determined through the continued efforts of
structural biology/genomics.’’
That is, the methodology is likely to be repeated for other
organisms and/or repeated in the same organism as more drugs
become available and/or more of the structural proteome
becomes available. The original work did not use a workflow
system; instead the computational steps were run separately and
manually. The original work was done over a period of two years,
with different authors having different degrees of participation in
the design and the programming aspects of the study. There is a
TB Drugome project site where many details about the work can
be found [35].
The original article was used to challenge participants at the first
Beyond the PDF workshop [21]. The workshop attracted participants interested in bettering the communication and comprehension of science. The challenge was to apply the tools they had
developed to illustrate their value on a given piece of science to
which, as far as possible, all lab notes, raw data, software, drafts of
the paper etc. where made available. The work described here is
one outcome of these efforts and is aimed at addressing the
questions: What can we gain from the process of workflow creation
and what does it tell us about reproducibility?
The rest of this paper describes our attempt to answer these
questions. Many details of the analysis and how progress was made
in reproducing the method are available on the project site [36].
Also Supplement S1 includes a more detailed analysis and the
thought processes that occurred.

we believe methods to be, for the most part, described informally
as formalizations are not typically favored by authors or enforced
by reviewers.
Computational methods are often complex and hard to explain
in textual form with the given space limitations of many articles. As
a result, reproducing methods often requires significant effort from
others to reproduce and reuse. Studies have shown that
reproducibility is not achievable from the article itself, even when
datasets are published [5–7]. The reproducibility process can be so
costly that it has been referred to as ‘‘forensic’’ research [8]. Lack
of reproducibility also affects the review process and as a result
retractions of publications occur more often than is desirable [9].
A recent editorial proposed tracking the ‘‘retraction index’’ of
scientific journals to indicate the proportion of published articles
that are later found problematic [10]. Publishers themselves are
asking the community to end ‘‘black box’’ science that cannot be
easily reproduced [11]. Pharmaceutical companies report abandoning efforts to reproduce research that seemed initially
promising and worth investigating after substantial investments
[12].
Computational reproducibility is a relatively modern concept.
The Stanford Exploration Project led by Jon Claerbout published
an electronic book containing a dissertation and other articles
from their geosciences lab [13]. Papers are accompanied by zipped
files with the software that could be used to reproduce the results,
and a methodology was developed to create and manage all these
objects that continue today with the Madagascar software [14].
Advocates of reproducibility have sprung up over the years in
many disciplines, from signal processing [15] to psychology [16].
Organized community efforts include reproducibility tracks at
conferences [17–19], reproducibility editors in journals [20], and
numerous community workshops and forums (e.g., [21], [22]).
Active research in this area is addressing a range of topics
including copyright [23], privacy [24], social [25] and validation
issues [26].
Scientific publications could be extended so that they incorporate computational workflows, as many already include data [1].
Without access to the source codes for the papers, reproducibility
has been shown elusive [7]. This would make scientific results
more easily reproducible because articles would have not just a
textual description of the computational process used but also a
workflow that, as a computational artifact, could be inspected and
automatically re-executed. Some systems exist that augment
publications with scripts or workflows, such as Weaver for Latex
[27–28] and GenePattern for MS Word [29]. Many scientific
workflow systems now include the ability to publish provenance
records [30–31]. The Open Provenance Model was developed by
the scientific workflow community and is extensively used for this
purpose [32]. Here we make a contribution to the on-going
discussion of reproducibility by attempting to quantify what
reproducibility implies.

Methodology
The workflow was reproduced as a joint effort between
computer scientists and the original authors of the article.
Although some of the authors of the paper had moved to other
research groups (notably Kinnings, its first author), they were still
available to answer questions and provide software scripts and
data as needed.
We present a detailed analysis of the issues that came up in
reproducing three major parts of the methods section in the
original paper. These three parts were originally fully automated.
Other steps of the method, notably the initial steps to obtain the
data and the final steps for visualization and presentation, were
manually done and not considered as part of the workflow
presented here.
We describe how each of the three method subsections was
implemented as a workflow. Each computational step corresponds
to an execution of an existing tool or a script written by the paper
authors. We were able to recreate the workflow in the Wings
workflow system [37–39] to make sure it was executable and
reproduced the original results reported in the paper. Hence, the
workflow explicitly represents the method that the authors meant
to convey in the original text, that is, the process by which software
and data are used to achieve the published result.

Methods and Analysis
Quantifying Reproducibility
We focus on an article that describes a method that lends itself
to workflow representation, since others can, in principle, use the
same exact procedures [4]. The article describes a computational
pipeline that, as applied, maps all putative FDA and European
drugs to possible protein receptors within a given proteome;
Mycobacterium tuberculosis (TB) in the paper under study.
Mapping is limited to the accessible structural proteome of
experimental structures and high quality homology models.
Mapping is performed using a binding site comparison algorithm
PLOS ONE | www.plosone.org
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REP-NOVICE reproducers were able to figure out this parameter.
For this analysis, we assigned a reproducibility score to each
aspect of the workflow for each of these reproducer categories. A
score of 1 in a category means that, in our assessment, a
prototypical researcher of that category would be able to figure out
the item. A score of 0 means that they would not be likely to figure
it out without help from experts.
Based on these scores, we designed a reproducibility map,
where the reproducibility of each computational step was
highlighted to determine how far each category of researcher
could go in reproducing a given workflow fragment.
Finally, we report on the effort involved in creating the
workflow, measured as the time spent on various aspects of the
work involved in reproducing the method described in the original
article.

Based on this explicit computational workflow, we present an
analysis of the reproducibility of each subsection. We considered
reproducibility by researchers of four types:
1. REP-AUTHOR, is a researcher who did the original work
and who may need to reproduce the method to update or
extend the results published. It is assumed that the authors have
enough backup materials to answer any questions that arise in
reconstructing the method. In practice, some authors may be
students that move away from the lab and their materials and
notes may or may not be available, confounding reproducibility
[40].
2. REP-EXPERT is a researcher familiar with the research area.
These researchers could reproduce the method even if the
methods section of the paper is incomplete and ambiguous.
They can use their knowledge of the domain, the software tools
and the process to make very complex inferences from the text
and reconstruct the method. However, there may be some nontrivial inferences that require significant effort.
3. REP-NOVICE is a researcher with basic bioinformatics
expertise. They may be asked to use the method with new
data, but are only able to make limited inferences based on
analyzing the text and software tools. For them reproducibility
can be very costly since it may involve a lot of trial and error, or
perhaps additional research. In some cases reproducibility may
become impossible.
4. REP-MINIMAL is a researcher with no expertise in
bioinformatics. They need some programming skills to
assemble the software necessary to run the different steps of
the method. They represent researchers from other areas of
science with minimal knowledge about biology, students, and
even entrepreneurial citizen scientists (e.g., [41]). Unless the
steps of the method are explicitly stated, they would not be able
to reproduce the results.

Conceptual Overview of the Method and Final Workflow
An interesting result of our initial discussions of the method was
a collaborative diagram that indicated each of the steps in the
method and how data were generated and used by each step. This
diagram, shown in Figure 1, makes the steps of the method more
explicit and adds useful information to the text in the methods
section. It also shows where the data in the tables of the article fit
into the method.
In essence, the bulk of the results in the paper are obtained
through three major steps:
1. Comparison of ligand binding sites, which compares the putative
binding sites of solved protein structures and homology models
(obtained from queries to the PDB and other sources) against
the binding sites from protein structures where approved drugs
are bound. This step used the SMAP software [42].
2. Comparison of protein structures, optimizing their alignment as well
as reporting on the statistical significance of the structural
similarity. This step used the FATCAT software [43] and is in
essence a filtering step to remove structures which have overall
global similarity and hence likely to be in the same protein
family, since we are interested in similar binding sites found in
otherwise dissimilar proteins.
3. Molecular docking, to predict the binding and affinity of the
proteins and drug molecules. This step used the eHits software
[44].

In our work, we did not ask experts to reproduce the method, so
we only have three categories of researcher rather than four. We
used the following approach:

N
N

N

REP-MINIMAL - The computer scientists in the team read
the article and formulated the initial workflows. They have
minimal background knowledge in biology.
REP-NOVICE - The computer scientists subsequently
consulted the documentation on the software tools mentioned
in the article to try to infer how the data were being processed
by each of the steps of the method. Based on this, they refined
their initial workflows.
REP-AUTHOR - Lastly the computer scientists approached
the original paper authors to ask specific questions, resolve
execution failures and errors and consult concerning the
validity of the results for each step. They created the final
workflow based on these conversations with the authors.

Based on our experience, authors should be encouraged to publish such high-level flow diagrams as a
normal part of the materials and methods section of a
paper. The diagrams provide a high level overview of the
method, highlights major steps, and offer a roadmap for
reproducibility.
The final workflow with the four steps that reproduced the
method is shown in Figure 2. We highlight the first three major
subsections of the method. In order to validate the new results, we
used the same inputs (drug binding sites, solved structures, and
homology models) as in the original work. However, these inputs
point to external data sources (like the PDB) where the data are
stored. These third-party data sources had been updated, and
therefore the workflow execution produced slightly different results
than the results reported in the original article. A detailed
comparison of the original results and the results of the new
workflow is provided in Supplement S1.

We analyzed each of the workflow steps in terms of: whether the
existence of the step itself was clear to the reproducers, whether the
software that was used to run the step was clear to the reproducers,
and whether their inputs and outputs were clear. For example, the
existence of a step to compare ligand binding sites is mentioned in
the text of the original paper, and the fact that it was carried out
using the SMAP software [42] is also explicit in the text, so those
would be things that the REP-MINIMAL reproducers were able
to figure out. The use of a p-value as an input was not mentioned
in the text and cannot be easily inferred unless the researcher
reproducing the method becomes familiar with the software, so
PLOS ONE | www.plosone.org
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Figure 1. A high-level dataflow diagram of the TB drugome method.
doi:10.1371/journal.pone.0080278.g001

the data used in the original experiment, but also the
configuration files used.
It also became clear that the data published as tables in the
original article were not the direct input to the SMAP software,
and some transformations would be required in order to use these
data in the workflow. We recommend that when data is
published in formats that make it more readable, the
actual data that is input for software to run also be made
available.
Another issue concerned the constant evolution of the software
tools that are used for the method steps. In our case, the SMAP
software had evolved since the publication of the original paper.
As with many software tools used in biology, SMAP is an active
research effort and its functionality continues to improve. When
the workflow was reproduced there was a new version of SMAP
that had the same basic functionality, but produced slightly
different results. Under normal research circumstances, it is not
critical that the workflow reproduce the exact execution results,
but that the conclusions drawn from those results still hold. An
interesting result would be if the workflow was run again with a
newer more powerful tool and there were additional findings over
and above the original publication. The same can be said for new
and more comprehensive sources of input data. The possibility
of easily re-running and checking the method periodically with new versions of software tools and/or data
that might lead to additional findings may entice
researchers to keep their methods more readily reproducible.
Global comparison of protein structures. Inspecting the
scripts used by the authors revealed two steps for this subsection
not mentioned in the original article. The first step generates a list
of significant comparisons, which is used in the second step to

Reproducibility Analysis
We now analyze each of the subsections of the method as
described in the original paper, discussing the difficulties
encountered in reproducing the method, highlighting recommendations to improve reproducibility, and show reproducibility
scores for each step of the final workflow. An extended analysis
of each subsection of the method is available in Supplement S1,
detailing the evolution of each sub-workflow in order to achieve
the final result.
Comparison of ligand binding sites. The initial workflow
design used a single step to compare the three items: the binding
sites of experimental structures, the binding sites of the homology
models, and the binding sites of the proteins to which drugs were
bound. Examining the SMAP software and associated scripts
revealed that comparison occurred in two steps: one to compare
the experimental binding sites with the drug binding sites, and one
to compare the homology model binding sites with the drug
binding sites.
To clarify how the outputs of both SMAP invocations were
combined, the authors provided the script that invoked the SMAP
software. This revealed a new step for sorting the results. In
addition, there was an additional step where the results below a
given p-value were filtered out.
The SMAP software has several configuration parameters.
Without the author’s configuration files, default values of the
parameters were used not knowing if the workflow would produce
questionable results. That is, it is not clear whether without the
same parameter settings the original method would be reproduced
and similar results would be obtained. For these reasons, the
original configuration files were obtained from the authors. This
suggests that it would be good practice for authors to
publish not just a description of the software used and
PLOS ONE | www.plosone.org
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Figure 2. The reproduced TB Drugome workflow with the different subsections highlighted. (1) Comparison of ligand binding sites using
SMAP; (2) protein structure comparison using FATCAT; (3) docking using Autodock Vina; and (4) graph network creation (visualization). We focus on
the reproducibility of sections 1-3 here.
doi:10.1371/journal.pone.0080278.g002

from the authors. Authors should be encouraged to publish any
software and parameter files that were written by them and that
became part of the method, because public domain software tools
are only part of the software required to reproduce the method.
An important issue regarding reproducibility came up in this
subsection of the workflow. Although the method was reproduced
with all of the necessary steps, the execution of the FATCAT step
failed. The reason for the failure was that some of the PDB
(protein) ids used in the input list had been superseded by newer
structures in the PDB. Therefore, an additional component was
added to check availability and replace any obsolete protein with

remove significantly similar pairs of global structures from the
FATCAT output. An expert in the domain would infer the need
for these steps from the published article – only one structure from
a set with similar global structures is needed to reach the
appropriate conclusions. The article mentions the use of a
threshold of 0.05, but this value did not appear in any parameter
file. The FATCAT documentation mentions that 0.05 is a default
value used to filter results, so this threshold did not have to be
reflected in the workflow since it was fixed by the software – hard
for a novice to know. Thus the workflow for this subsection could
not be recreated just from the article alone, but required the scripts

PLOS ONE | www.plosone.org
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reproduce seven of the fourteen steps: the six steps to compare
ligand binding sites, only one of the four steps to compare the
protein structures, and none of the steps for docking. For docking,
our conclusion was that only expert researchers with advanced
knowledge of the domain would be able to reproduce the steps.
The original software was no longer available, and advanced
expertise was required to identify equivalent software to replace it,
and to write the software necessary to make it work as needed.
Expert researchers would be able to reproduce the method, as the
original article combined with the data and software published in
the site would be sufficient to infer any missing information. A
detailed rationale for the scores can be found in the reproducibility
scores subsection of Supplement S1.
Regarding the results, we checked that the output of the
workflow included all the drugs exposed in the original work (plus
new findings). The ranking of drugs in the results of the workflow
is almost the same as the original, although the number of
connections found for each drug is significantly higher in the
results of the workflow. A possible reason is changes in the version
of the software tools and updates to the external databases where
the structures are stored. A detailed comparison can be seen in the
original results versus results from the workflow subsection of Supplement
S1.

its superseded version. This issue will not be unusual in
reproducibility. Many experiments rely upon third party data
sources that change constantly. Consequently, it is to be expected
that these sources may not always be available and that the results
that they return for the same given query may not always be the
same. In our case, the changes in the PDB were addressed by
adding a step that updated the older IDs with the new ones. This
suggests that some published results that depend on
third party data sources may not always be reproducible
exactly, so it would be good practice to publish all
intermediate data from the experiment so that the
method followed can be examined when re-execution is
not possible. An alternative is that data archives provide
access to their contents for each version.
Docking. The raw interaction network resulting from the first
subsection of the method (comparison of ligand binding sites) was
assumed to be the input for docking. It turns out that although the
input for docking is data produced by SMAP, it is not the raw
interaction network that it outputs. Instead, it is data that SMAP
places in an ‘‘alignment’’ folder - only expert users would be aware
of this.
The original article refers to adding cofactors to relevant
proteins prior to docking, which could be interpreted to be a step
prior to docking. As it turns out, there is no explicit step for
handling the cofactors since this is handled by manually editing the
appropriate PDB file. Again, only expert users would be aware of
this.
Examination of the author’s scripts revealed some additional
steps: calculating the clip files, which are used for obtaining the
ideal ligands before docking. Clip files are mentioned in the article
as containing the aligned drug molecules, so it would seem to a
non-expert that the aligned molecules would be the output of the
initial alignment steps of the overall method.
A major issue with this portion of the workflow is that the
docking software used for the original article was no longer used in
the laboratory. It is proprietary software, and its license had
expired, so alternative software (AutodockVina) with similar
functionality has been adopted since the original article was
published. Some of the ligands were not recognized by this
software, so a transformation step had to be added to the workflow
to make Autodock Vina work correctly.
There are reasons why authors use proprietary software, for
example, ease of use, support, robustness, visualization and data
types supported. However, the authors could replicate the method
before publication using open source tools, which would facilitate
reproducibility by others. The use of open source software
instead of proprietary software facilitates the reproduction of the software steps originally used by the authors,
and should be the preferred mode of publication of
methods and workflows.

Productivity and Effort
We kept detailed records in a wiki of the effort involved in
reproducing the method throughout the project. These records are
publicly available from [36].
We estimated the overall time to reproduce the method as
280 hours for a novice with minimal expertise in bioinformatics.
The effort included analyzing the paper and the original author’s
web site and additional materials (data, scripts, configuration files)
to understand the details of the method, locating and preparing
the codes, finding appropriate parameter settings, implementing
the workflows, asking questions to the authors when necessary, and
validating the workflows. It should be noted that the authors of the
original experiment were available to answer questions (notably
Kinnings, the first author). These questions were related to missing
configuration parameters, documentation for the proper invocation of the tools, and validation of the outcome of the intermediate
steps. Table 1 estimates the time required to reproduce the
method and is broken down by major tasks according to our
records.

Publishing the Reproduced Workflow
Now that we had invested significant effort in reproducing the
workflow, our goal was to maximize its reusability.
First, the executed workflow was published using the Open
Provenance Model [32]. This model is used by many workflow
systems, so it increases the workflow reusability because it can be
imported into other systems depending on the preference of the
particular research group. We also publish the workflow provenance using the PROV ontology [45], a recent standard for
provenance from the W3C [46]. This makes the published
workflow independent of the workflow system used to create it.
Second, we published an abstract workflow that complements it.
The abstract workflow describes the steps in a manner that is
independent of the software used to implement them. For this we
used an extension of the Open Provenance Model called OPMW
[47] that includes new terms to describe abstract steps.
Third, we published the workflow and all of its constituents
(including input and output data, software and scripts for the steps)
as Linked Data [48], which means that each constituent of the
workflow can be accessed by its URI through HTTP, and its

Reproducibility Maps
We present reproducibility maps created as a summary of the
reproducibility scores for all the major steps in the workflow.
Figure 3 shows the reproducibility maps for each of the
subsections, summarizing the reproducibility scores assigned to
each step. For each section of the method, we show a progression
of steps from left to right, noting on the right hand side the
category of reproducer represented (MINIMAL, NOVICE, and
AUTHOR). A step is shown in red if it was not reproducible by
that category of user, and green if it were.
Our observation was that a researcher with minimal knowledge
of the domain would only be able to reproduce one of the fourteen
steps in the workflow. A novice researcher would be able to
PLOS ONE | www.plosone.org
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Figure 3. Reproducibility maps of the three major subsections of the workflow. A step is shown in red if it was not reproducible by that
category of user, and green if it were.
doi:10.1371/journal.pone.0080278.g003

properties are described using W3C RDF standards [49]. This
means that the published workflow is accessible over the Web, in a
way that does not require figuring out how to access institutional
catalogs or file systems.
With this maximally open form of publication of the workflow,
the effort that we invested in reproducing the workflow does not
have to be incurred by others. Each step and its inputs and outputs
are explicitly and separately represented as well as linked to the
workflow. The software for each step is available as well, as are the
intermediate and final results.
The effort involved in creating a workflow is negligible
compared with the time to implement the computational method.
Implementing the computational method typically takes months,
and involves activities such as finding software packages that
implement some of the steps, figuring out how to set up the
software (e.g., setting up parameters) to suit the data, and writing
new code to reformat the data to fit those packages. Once this is all
done, creating the workflow can be done in a few hours, and can
be as simple as wrapping each step so it can be invoked as a
software component and expressing the dataflow among the
components. Learning to create simple workflows requires only a
few hours, more advanced capabilities clearly require additional
time investment (e.g., running workflows in a cluster, depositing

Table 1. Time to reproduce the method.

Tasks

Time (hours)

Familiarization with workflow and running software

160

SMAP steps

32

SMAP result sorter steps

8

Merger steps

4

Get significant results

4

FATCAT URL checker

8

FATCAT step

4

Remove significant pairs

4

Create clip files

8

Create ideal ligands

8

Ideal ligand checker

8

Autodock Vina

16

Data visualization steps

16

TOTAL

280 hours

doi:10.1371/journal.pone.0080278.t001
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Table 2. Observations and desiderata for reproducibility.

Observation

?
?
?
?

We found that important computational steps were either missing or ambiguous. The paper should make clear all computational steps needed by a novice

user.
Software is often used with carefully selected parameter settings and configurations. It would be good practice for authors to publish not just a description

of the software and data used, but also to publish any parameter settings and configuration files used.
The possibility of re-running the method periodically with new versions of software tools leading to new findings might help entice researchers to keep their methods

readily reproducible.
Published results that depend on third party data sources may not always be accessible and may make the experiments run by the original authors irreproducible.

Where practical, authors should publish all intermediate data from the experiment so that the method they followed can be examined when direct
re-execution is not possible.

?

To implement some steps of their methods, authors often use proprietary software or software that is not widely available. The use of open source software

facilitates the reproduction of the software steps originally used by the authors, and should be the preferred mode of publication for authors of
methods and workflows.

?

Although many methods are implemented by using public domain software tools, they often contain additional steps that were implemented by the authors. To

facilitate reproducibility, authors should publish any software written by them and that became part of the method.
doi:10.1371/journal.pone.0080278.t002

for highly repetitive tasks, they are less used for earlier stage
research. Whether this is a result of shortcomings in the tools or
insufficient emphasis on the need to make work reproducible
requires further consideration. This then raises the further issue of
whether the emphasis itself is justified. Do we really care if work is
exactly reproducible? This generally only becomes important if
some variation of the original work cannot be reproduced at all,
then the original work is fully scrutinized. This speaks to a need for
better quantification of what is really needed to improve
productivity in science. When, as is the case here, the experiment
is conducted completely in silico, the opportunity to accurately
capture what has transpired becomes a relatively straightforward
task (i.e., there is a relatively favorable cost:benefit ratio) and raises
the question as to whether the community of computational
biologists should do better. What does doing better imply?
We believe it is rare that work is purposely made irreproducible;
rather the system of peer review speaks to reproducibility but is
cursory in demanding it. The scientific reward is in publishing
another paper, not making your current paper more reproducible.
Tools help, but changes in policy are also needed. It will be a brave
publisher indeed that demands that workflows be deposited with
the paper. Publishing after all is a business and if one publisher
demands workflows, authors are more likely to publish elsewhere
than go to the trouble. Journals are beginning to provide
guidelines for reproducibility and minimum requirements for

results in a catalog, or expressing a complex control flow).
Similarly, publishing workflows takes no effort at all since the
workflow system takes care of the publication.
Technical details on how the workflow is published can be
found in [50]. The OWL ontologies for OPM and PROV that
express all the underlying RDF properties can be browsed from
[51]. All the materials related to the workflow and its execution
results have been published online [36]. Additionally, input and
output datasets have been associated to DOIs and uploaded to a
persistent data sharing repository [52].

Discussion
Reproducibility is considered a cornerstone of the scientific
method and yet rarely is scientific research reproducible without
significant effort, if at all [5-7]. Authors submitting papers know
this; as do those reading the papers and trying to reproduce the
experiment. For computational work like that described here,
where data, methods, and control parameters are all explicitly
defined there is less of an excuse for not making the work
reproducible. Note that making the software available or accessible
through a webserver, while commendable, is not the same as
making the work reproducible. Workflows, which define the
scientific process as well as all the components, provide the tools
for improved reproducibility. While workflows are commonly used
Table 3. Reproducibility Guidelines for Authors.

Guideline
1. Input data: Provide the original datasets used in the experiment reported in the paper
2. Dataflow Diagram: Provide a diagram that represents a dataflow of the computational steps. The nodes in the graph should be computational steps, which include
invocations of software tools, scripts and other software that were written, and any additional data manipulations that were carried out manually. The links in the graph
specify the dataflow, which indicates what the input data for each step are and links to other steps that may have generated the data.
3. Software: Prefer open software tools that are appropriately documented. Specify the software tools used mentioning versions and download dates. For any scripts
or other software that were written, provide the code itself or at least ‘‘pseudo-code’’ (i.e., an informal version of the code that is language-independent)
4. Configurations: Provide the values of any parameters and configuration files used
5. Intermediate data: Provide key intermediate data that resulted from important steps and that would help others determine whether they reproduced the method
correctly
doi:10.1371/journal.pone.0080278.t003
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open source-minded community, adoption is increasing. Adoption
would assume a favorable cost:benefit ratio in that use of a
workflow system provides increased productivity over not using
such a system. This is a cost measured in time rather than money
since most academic laboratories in computational biology would
use free open source workflow systems. Finally, when articles
cannot be easily reproduced the authors are often contacted to
clarify or describe additional details. This requires effort that
might as well have been invested in writing the article more
precisely in the first place.
Workflows can also be seen as an important tool to make the
research in a lab more rigorous. Analyses must be captured so they
can be inspected by others and errors detected as easily as possible.
For example, writing code to transform data makes the transformation inspectable, while using a spreadsheet to do the task makes it
much harder to verify that it was done correctly. Ensuring
consistency and reproducibility requires more effort without
workflows. In our own laboratory we find that the workflow can
act as a reference such that new users can more quickly familiarize
themselves with the various applications than would be the case
without the benefit of the workflow organization, but then choose to
go on and run applications outside of the workflow system. As the
workflow systems themselves continue to be easier to use and more
intuitive we anticipate that more work will be done within the
workflow system itself, presumably improving productivity.
For the practitioner, what are the pluses and minuses of
workflow use today? An obvious minus is the time required to
establish the workflow itself. In some sense this is analogous to
documenting a procedure to run a set of software programs. But in
most cases once codes are prepared for publication little additional
effort is required to include them in a workflow. The advantage of
a workflow is that capturing the steps themselves defines the
procedure and it can be re-run, in principle, without any further
effort. We say ‘‘in principle’’ since as this work has shown
workflows decay – the tools available change, the licenses to those
tools change, remote data accessibility changes etc. Virtual
machines offer the promise of capturing the complete executable
environment for future use, however they introduce other issues
[26]. For example, virtual machines often act as black boxes that
allow repeating the experiment verbatim, but do not allow for any
changes to the computational execution pipeline, limiting its
reproducibility. Furthermore, virtual machines cannot store
external dynamic databases accessed at runtime (like the PDB in
our work) due to their size. These databases are commonly used
for experiments in computational biology.
All taken together, it may be that we are at this tipping point of
broad workflow adoption and it will be interesting to review
workflow use by the computational biology community two or
more years from now.

method descriptions [53–54]. There is already a concept of ‘‘data
publication,’’ where datasets are described and receive a unique
identifier and a publication. Similarly, there should be a concept of
‘‘workflow publication.’’ There is no explicit credit for publishing
software packages, and many people do it. The credit comes
indirectly from acknowledgement by the community that the
software is useful. Perhaps publishing end-to-end methods as
workflows would bring similar reputation. For this to work,
authors must be recognized and credited by other researchers
reusing their workflow. We posit that the authors of the original
method need not be the ones publishing the workflow. Third
parties interested in reproducing the method could publish the
workflow once reproduced, and get credit not for the method but
for the workflow as a reusable software instrument. In one sense
this is no different than taking other scientists data and developing
a database that extends the use of these data to a wider
community. It is a value-added service worthy of attention
through publication.
Federal mandates similar to those emerging around shared data
could also be put in place for reproducibility too. In the end,
funding for science ultimately comes from taxes from the public,
and we need to be responsible in making science as efficient and
productive as possible. Many government agencies already require
data to be published and shared with other researchers. Workflows
should follow the same path. The recent emphasis on open
availability of research products resulting from public funds [55–
56] will eventually include the publication of software and the
methods (workflows). This will likely be sometime coming as the
easier issue of meaningful data provision is not fully understood
and solved yet. Notwithstanding, if this remains a difficult issue on
a global scale we can make progress in our own laboratories.
A new researcher coming to almost any laboratory and picking
up tools used by previous laboratory members can likely testify to
what is described in this paper. If we are to accelerate scientific
discovery we must surely do better both within a laboratory and
beyond. This is particularly important in an era of interdisciplinary
science where we often wish to apply methods that we are not
experts in. Some would argue that irreproducibility in the
laboratory is part of the learning process; we would argue yes,
but with so much to learn that is more relevant to discovery we
should do better now that we have tools to assist us.
Or should we? Reproducibility aside, is there indeed a favorable
cost:benefit ratio in using workflows with respect to productivity?
There is a dearth of literature that addresses this question. Rather
the value of the workflow is assumed and different workflow
systems on different computer architectures are analyzed for their
relative performance. At best the question can be addressed by
work habits. We must be careful as such work habits could be
mandated, in a large company say, rather than by choice, which
would be the case in an independent research laboratory. Creating
workflows results in overhead for exploratory research, where
many paths are discarded. However, once created a workflow can
be reused many times. This makes them ideal for repetitive
procedures such as might be found in aspects of the pharmaceutical industry. Pharmaceutical companies use workflows for
computational experiments [57]. This means there must be a
business case for workflows in terms of saving time and effort and/
or facilitating quality control. Taking an independent computational biology laboratory, as is the case for this study, it is fair to
say that workflows are making inroads into daily work habits.
These inroads are still localized to specific subareas of study –
Galaxy [58] for high-throughput genomic sequence analysis;
KNIME [59] for high-throughput drug screening, and so on, but
with that nucleation and with new applications being added by an
PLOS ONE | www.plosone.org

Conclusions
We conclude by summarizing the main observations resulting
from our work, leading to desiderata for reproducibility shown in
Table 2, and a set of guidelines for authors shown in Table 3. We
have restrained from making too many absolute conclusions from
a single instance of applying a workflow to a scientific method. It
would be interesting to carry out similar studies in other domains
and compare findings.
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